Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check3 days agoChange DetectedCystic fibrosis and MedlinePlus Genetics topics were removed from the page, affecting visibility of CF-related study details and resources.SummaryDifference0.2%

- Check10 days agoChange DetectedUpdates include adding 'Cystic fibrosis' to related topics, a MedlinePlus Genetics reference, and a revision note (v3.3.3), along with the removal of the HHS Vulnerability Disclosure entry (v3.3.2); no core study content, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check17 days agoChange DetectedRemoved the condition 'Cystic Fibrosis' from the study details and deleted the related topic link 'MedlinePlus Genetics'. This reduces explicit context about the study population and available background resources.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, a minor update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded related topics Cystic fibrosis and MedlinePlus Genetics, and updated the revision from v3.2.0 to v3.3.1.SummaryDifference0.2%

- Check46 days agoChange DetectedRemoved the temporary government funding lapse notice from the page, including references to cc.nih.gov and opm.gov. The page now presents study details without that operational alert.SummaryDifference0.4%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.